Mishima, Japan

Kozo Yoshida

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kozo Yoshida. Retrieved from https://idiyas.com/inventor/kozo-yoshida-5s4dxcz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kozo Yoshida: Innovator in Erectile Dysfunction Remedies

Introduction

Kozo Yoshida is a prominent inventor based in Mishima, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of erectile dysfunction. His innovative approach has led to the development of effective remedies that utilize prostaglandin derivatives.

Latest Patents

Yoshida holds a patent for "Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient." This patent focuses on therapeutic agents for erectile dysfunction that contain prostaglandin derivatives of a specific formula. The compounds are designed to be effective in treating erectile dysfunction, showcasing Yoshida's commitment to improving men's health.

Career Highlights

Throughout his career, Kozo Yoshida has been associated with Ono Pharmaceutical Co., Ltd., where he has worked on various projects aimed at enhancing therapeutic solutions. His expertise in pharmacology and innovative thinking has positioned him as a key figure in the development of new medical treatments.

Collaborations

Yoshida has collaborated with notable colleagues, including Kazunori Kimura and Masami Narita. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.

Conclusion

Kozo Yoshida's contributions to the field of erectile dysfunction remedies highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the pharmaceutical industry and offers hope for many individuals seeking effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…